There were no safety concerns identified among older adults following revaccination with the investigational respiratory syncytial virus vaccine mRNA-1345, and immune responses elicited by ...
Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...
GlobalData on MSN19h
mRNA licensing agreements surge 800% amid GSK lawsuitsConsidering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...
The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...
(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of ...
GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
GlaxoSmithKline has filed lawsuits against Moderna in a Delaware federal court, alleging infringement of patents related to ...
Zacks.com on MSN9d
GSK Posts New Data From Phase III Study on RSV Vaccine ArexvyNew data from GSK's phase III study evaluating a single dose of RSV vaccine Arexvy indicates protection over three RSV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback